Skip to content
Search

Latest Stories

Fake Ozempic: Several people admitted to a hospital in Austria

The patients have suffered serious side effects due to injected insulin instead of semaglutide

It has been reported that several Austrians have been taken to the hospital after injecting fake Ozempic, as confirmed by health regulator.


Austria's Federal Office for Safety in Health Care (BASG) confirmed that the patients have suffered hypoglycaemia and seizures.

It is believed that the injections contained insulin instead of the weight loss drug, semaglutide.

The health regulator has urged doctors and patients to verify their medication stocks.

The surge in the sale of fake Ozempic has been flagged by the drug’s Danish manufacturer, Novo Nordisk.

They said: “We recognize the limitations of this exercise and are conducting physical investigations where warranted.”

Last week, the European Medicines Agency (EMA) and Medicines and Healthcare Products Regulatory Agency (MHRA) warned that fake Ozempic is in circulation throughout Europe and the UK.

However, earlier this week, they also confirmed to have identified two wholesalers hoarding the drug.

The MHRA issued a statement: "All affected pens have been recalled and accounted for, and none of the pens have been supplied to UK patients."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less